173 related articles for article (PubMed ID: 24986893)
1. Ivabradine and atrial fibrillation: what should we tell our patients?
Cowie MR
Heart; 2014 Oct; 100(19):1487-8. PubMed ID: 24986893
[No Abstract] [Full Text] [Related]
2. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
3. The Role of Ivabradine in the Management of Angina Pectoris.
Giavarini A; de Silva R
Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
[TBL] [Abstract][Full Text] [Related]
4. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
[TBL] [Abstract][Full Text] [Related]
5. Ivabradine for chronic heart failure?
Drug Ther Bull; 2012 Oct; 50(10):117-20. PubMed ID: 23065752
[TBL] [Abstract][Full Text] [Related]
6. Rate control with ivabradine: angina pectoris and beyond.
Parakh N; Bhargava B
Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine for rate control in atrial fibrillation.
Kosiuk J; Oebel S; John S; Hilbert S; Hindricks G; Bollmann A
Int J Cardiol; 2015 Jan; 179():27-8. PubMed ID: 25464400
[No Abstract] [Full Text] [Related]
8. Ivabradine: Do the Benefits Outweigh the Risks?
Alshammari TM
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):210-218. PubMed ID: 27698078
[TBL] [Abstract][Full Text] [Related]
9. [Ivabradine -- a novel approach for heart rate lowering].
Er F; Hoppe UC
Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
[No Abstract] [Full Text] [Related]
10. Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
Eur Heart J; 2015 Dec; 36(46):3291-6. PubMed ID: 26385957
[TBL] [Abstract][Full Text] [Related]
11. Focus on ivabradine: a new heart rate-controlling drug.
Riccioni G
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
Martin RI; Pogoryelova O; Koref MS; Bourke JP; Teare MD; Keavney BD
Heart; 2014 Oct; 100(19):1506-10. PubMed ID: 24951486
[TBL] [Abstract][Full Text] [Related]
13. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
Canet E; Lerebours G; Vilaine JP
Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Borer JS; Le Heuzey JY
Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
[TBL] [Abstract][Full Text] [Related]
15. [From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines].
Lopatin IuM
Kardiologiia; 2011; 51(5):85-90. PubMed ID: 21649600
[TBL] [Abstract][Full Text] [Related]
16. Limited role and benefit of ivabradine in the treatment of angina and heart failure with reduced ejection fraction.
Ennezat PV; Cosgrove S; Marechaux S; Bouvaist H; Le Jemtel TH; Vital Durand D
Acta Cardiol; 2017 Dec; 72(6):664-668. PubMed ID: 28656798
[TBL] [Abstract][Full Text] [Related]
17. [Ivabradine (pure heart-rate-lowering agent)].
Anzai T
Nihon Rinsho; 2011 Nov; 69 Suppl 9():412-6. PubMed ID: 22724239
[No Abstract] [Full Text] [Related]
18. Ivabradine: recent and potential applications in clinical practice.
Riccioni G
Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
[TBL] [Abstract][Full Text] [Related]
19. Ivabradine (Corlanor) for heart failure.
Med Lett Drugs Ther; 2015 May; 57(1469):75-6. PubMed ID: 25989196
[No Abstract] [Full Text] [Related]
20. The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients.
Tanboğa İH; Topçu S; Aksakal E; Gulcu O; Aksakal E; Aksu U; Oduncu V; Ulusoy FR; Sevimli S; Kaymaz C
Clin Cardiol; 2016 Oct; 39(10):615-620. PubMed ID: 27511965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
